COVID-19 Latest Updates

  • Printer Friendly Version
  • Decrease Text Size
  • Increase Text Size
  • PDF


Rosencrantz, Richard, MD 

Rosencrantz, Richard
Download Profile Download Profile

About

Language(s): English
Certification: Pediatric Gastroenterology, Pediatric Transplant Hepatology

Richard Rosencrantz, MD is the Medical Director of Pediatric Liver Transplant at Maria Fareri Children’s Hospital at Westchester Medical Center and Clinical Associate Professor of Pediatrics at New York Medical College, Division of Pediatric Gastroenterology and Hepatobiliary Diseases. Previously, he served on the faculties at Weill-Cornell Medical College and Yale School of Medicine.

Dr. Rosencrantz received his undergraduate degree in chemistry from Yeshiva College and his medical degree from New York Medical College. He completed a residency in Pediatrics at Long Island Jewish Medical Center, clinical and research fellowships in Pediatric Gastroenterology/Hepatology at Albert Einstein College of Medicine and a clinical fellowship in Pediatric Hepatology at The Mount Sinai Hospital.

Dr. Rosencrantz is board certified in Pediatric Gastroenterology and Transplant Hepatology.


View a list of Richard Rosencrantz's publications
Insurance: WMCHealth and WMCHealth Physicians accept most insurances, including Medicare and Medicaid. Please confirm your insurance with your provider’s office and if necessary, with our hospitals and diagnostic testing services.

Education

Medical School: New York Medical College
Internship: Long Island Jewish Medical Center
Residency: Long Island Jewish Medical Center
Fellowship:
Albert Einsein College of Medicine
The Mount Sinai Hospital

Specialties

Specialties: Hepatobiliary Disease
Pediatric Gastroenterology
Transplant Hepatology
Special Clinical Interest:
  • Acute liver failure
  • Alagille syndrome
  • Alpha-1-antitrypsin deficiency
  • Autoimmune hepatitis
  • Biliary atresia
  • Budd-Chiari syndrome
  • Familial and genetic cholestatic diseases
  • Cirrhosis
  • Cystic fibrosis
  • Drug induced liver injury
  • Hepatitis (autoimmune, non-alcoholic fatty liver disease (NAFLD / NASH), non-typeable, viral B and C)
  • Liver tumors (hepatoblastoma and hepatocellular carcinoma)
  • Metabolic liver diseases
  • Portal vein thrombosis
  • Pediatric solid-tumor care
  • Primary biliary cirrhosis
  • Primary sclerosing cholangitis
  • Wilson Disease

Locations

503 Grasslands Road, Suite 201
Valhalla, NY 10595
Phone: 914.367.0000
Fax: 914.367.0001